Characterization of the influence of semen-derived enhancer of virus infection on the interaction of HIV-1 with female reproductive tract tissues

Journal of Virology

Volumn 89, Issue 10, 2015, Pages 5569-5580

  Allen, Shannon A ^a   Carias, Ann M ^a   Anderson, Meegan R ^a   Okocha, Eneniziaogochukwu A ^a   Benning, Lorie ^d   McRaven, Michael D ^a   Kelley, Z L ^a   Lurain, John ^b   Veazey, Ronald S ^c   Hope, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEMEN DERIVED ENHANCER OF VIRUS INFECTION PROTEIN; SEMINAL PLASMA PROTEIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PROSTATIC ACID PHOSPHATASE (248-286), HUMAN; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHESUS MONKEY; SQUAMOUS EPITHELIUM; UTERINE CERVIX MUCOSA; UTERINE ENDOCERVIX; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS TRANSMISSION; ANIMAL; CHEMISTRY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUCOSA; PATHOGENICITY; PHYSIOLOGY; SPERM; TRANSMISSION; UTERINE CERVIX; VAGINA; VIROLOGY; VIRULENCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA;

ANIMALS; CERVIX UTERI; FEMALE; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACACA MULATTA; MALE; MUCOUS MEMBRANE; PEPTIDE FRAGMENTS; PROTEIN TYROSINE PHOSPHATASES; SEMEN; VAGINA; VIRULENCE;

EID: 84928542158     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00309-15     Document Type: Article

References (34)

1. Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Munch J. 2010. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7:55. http://dx.doi.org/10.1186/1742-4690-7-55.
2. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Gimenez-Gallego G, Sanchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F. 2007. Semenderived amyloid fibrils drastically enhance HIV infection. Cell 131:1059-1071. http://dx.doi.org/10.1016/j.cell.2007.10.014.
3. Bouvet JP, Gresenguet G, Belec L. 1997. Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect 3:19-23. http://dx.doi.org/10.1111/j.1469-0691.1997.tb00246.x.
4. Tevi-Benissan C, Belec L, Levy M, Schneider-Fauveau V, Si Mohamed A, Hallouin MC, Matta M, Gresenguet G. 1997. In vivo semenassociated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immunol 4:367-374.
5. Doncel GF, Joseph T, Thurman AR. 2011. Role of semen in HIV-1 transmission: inhibitor or facilitator? Am J Reprod Immunol 65:292-301. http://dx.doi.org/10.1111/j.1600-0897.2010.00931.x.
6. Sabatte J, Ceballos A, Raiden S, Vermeulen M, Nahmod K, Maggini J, Salamone G, Salomon H, Amigorena S, Geffner J. 2007. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 81: 13723-13734. http://dx.doi.org/10.1128/JVI.01079-07.
7. Stax MJ, van Montfort T, Sprenger RR, Melchers M, Sanders RW, van Leeuwen E, Repping S, Pollakis G, Speijer D, Paxton WA. 2009. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes. Virology 391: 203-211. http://dx.doi.org/10.1016/j.virol.2009.06.011.
8. Martellini JA, Cole AL, Venkataraman N, Quinn GA, Svoboda P, Gangrade BK, Pohl J, Sorensen OE, Cole AM. 2009. Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 23:3609-3618. http://dx.doi.org/10.1096/fj.09-131961.
9. Balandya E, Sheth S, Sanders K, Wieland-Alter W, Lahey T. 2010. Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV. J Immunol 185:7596-7604. http://dx.doi.org/10.4049/jimmunol.1002846.
10. UNAIDS. 2012. Report on the global AIDS epidemic 2012. UNAIDS, Geneva, Switzerland.
11. Usmani SM, Zirafi O, Muller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarstrom P, Wetzel R, Pilcher CD, Gagsteiger F, Fandrich M, Kirchhoff F, Munch J. 2014. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nat Commun 5:3508. http://dx.doi.org/10.1038/ncomms4508.
12. Collins KA, Bennett AT. 2001. Persistence of spermatozoa and prostatic acid phosphatase in specimens from deceased individuals during varied postmortem intervals. Am J Forensic Med Pathol 22:228-232. http://dx.doi.org/10.1097/00000433-200109000-00004.
13. Easterhoff D, DiMaio JT, Liyanage W, Lo CW, Bae W, Doran TM, Smrcka A, Nilsson BL, Dewhurst S. 2013. Fluorescence detection of cationic amyloid fibrils in human semen. Bioorg Med Chem Lett 23: 5199-5202. http://dx.doi.org/10.1016/j.bmcl.2013.06.097.
14. Munch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F. 2013. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology 10:148. http://dx.doi.org/10.1186/1742-4690-10-148.
15. Carias AM, McCoombe S, McRaven M, Anderson M, Galloway N, Vandergrift N, Fought AJ, Lurain J, Duplantis M, Veazey RS, Hope TJ. 2013. Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol 87:11388-11400. http://dx.doi.org/10.1128/JVI.01377-13.
16. Gupta P, Collins KB, Ratner D, Watkins S, Naus GJ, Landers DV, Patterson BK. 2002. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 76:9868-9876. http://dx.doi.org/10.1128/JVI.76.19.9868-9876.2002.
17. Hu J, Gardner MB, Miller CJ. 2000. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74:6087-6095. http://dx.doi.org/10.1128/JVI.74.13.6087-6095.2000.
18. Kaizu M, Weiler AM, Weisgrau KL, Vielhuber KA, May G, Piaskowski SM, Furlott J, Maness NJ, Friedrich TC, Loffredo JT, Usborne A, Rakasz EG. 2006. Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J Infect Dis 194:912-916. http://dx.doi.org/10.1086/507308.
19. Stieh DJ, Maric D, Kelley ZL, Anderson MR, Hattaway HZ, Beilfuss BA, Rothwangl KB, Veazey RS, Hope TJ. 2014. Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract. PLoS Pathog 10: e1004440. http://dx.doi.org/10.1371/journal.ppat.1004440.
20. Arjmandi N, Van Roy W, Lagae L, Borghs G. 2012. Measuring the electric charge and zeta potential of nanometer-sized objects using pyramidal-shaped nanopores. Anal Chem 84:8490-8496. http://dx.doi.org/10.1021/ac300705z.
21. Bondar OV, Saifullina DV, Shakhmaeva II, Mavlyutova II, Abdullin TI. 2012. Monitoring of the zeta potential of human cells upon reduction in their viability and interaction with polymers. Acta Naturae 4:78-81.
22. Roan NR, Munch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC. 2009. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol 83:73-80. http://dx.doi.org/10.1128/JVI.01366-08.
23. Roan NR, Sowinski S, Munch J, Kirchhoff F, Greene WC. 2010. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 285:1861-1869. http://dx.doi.org/10.1074/jbc.M109.066167.
24. Cone RA. 2009. Barrier properties of mucus. Adv Drug Deliv Rev 61:75-85. http://dx.doi.org/10.1016/j.addr.2008.09.008.
25. Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, Lakougna HY, Hammond C, Kiser PF, Hope TJ. 2013. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 6:427-434. http://dx.doi.org/10.1038/mi.2012.87.
26. Leblanc JJ, Perez O, Hope TJ. 2008. Probing the structural states of human immunodeficiency virus type 1 pr55gag by using monoclonal antibodies. J Virol 82:2570-2574. http://dx.doi.org/10.1128/JVI.01717-07.
27. Poonia B, Wang X, Veazey RS. 2006. Distribution of simian immunodeficiency virus target cells in vaginal tissues of normal rhesus macaques: implications for virus transmission. J Reprod Immunol 72:74-84. http://dx.doi.org/10.1016/j.jri.2006.02.004.
28. French KC, Roan NR, Makhatadze GI. 2014. Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection. Biochemistry 53:3267-3277. http://dx.doi.org/10.1021/bi500427r.
29. Bansil R, Turner BS. 2006. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci 11:164-170. http://dx.doi.org/10.1016/j.cocis.2005.11.001.
30. Lee S, Muller M, Rezwan K, Spencer ND. 2005. Porcine gastric mucin (PGM) at the water/poly(dimethylsiloxane) (PDMS) interface: influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties. Langmuir 21:8344-8353. http://dx.doi.org/10.1021/la050779w.
31. Carlstedt I, Lindgren H, Sheehan JK, Ulmsten U, Wingerup L. 1983. Isolation and characterization of human cervical-mucus glycoproteins. Biochem J 211:13-22.
32. Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, Lu Y, Felix AM, Maggio JE, Lee JP. 2000. The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol 130:130-141. http://dx.doi.org/10.1006/jsbi.2000.4288.
33. Mazoniene E, Joceviciute S, Kazlauske J, Niemeyer B, Liesiene J. 2011. Interaction of cellulose-based cationic polyelectrolytes with mucin. Colloids Surf B Biointerfaces 83:160-164. http://dx.doi.org/10.1016/j.colsurfb.2010.11.022.
34. McGill SL, Smyth HD. 2010. Disruption of the mucus barrier by topically applied exogenous particles. Mol Pharm 7:2280-2288. http://dx.doi.org/10.1021/mp100242r.